Canine Atopic Dermatitis Treatment Market will reach US$ 2.4 Bn by 2029 | Growth, Trends, COVID-19 Impact

Development of resistance to various therapeutic agents is contributing to increasing demand for immuno-specific drugs and vaccines. In this regard, scientists have noted that the production of monoclonal antibodies for canine atopic dermatitis treatment could prove largely helpful, and could be more stable as compared to biological drugs, which will create opportunity for the growth of the canine atopic dermatitis treatment market.

“Rising increase in the adoption of pets in developed countries and increasing influx of medical information over the Internet are factors promoting the growth of the canine atopic dermatitis treatment market.

FMI – a well-established name in the market research domain – forecasts that, the canine atopic dermatitis treatment market will experience a major upturn post 2026, reaching US$ 2.4 Bn by 2029.

Get Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4412

Key Takeaways of Canine Atopic Dermatitis Treatment Market Study

• Immunosuppressants are anticipated to be highly preferred treatment for canine atopic dermatitis, and contribute more than 45% revenue share in the canine atopic dermatitis treatment market.
• Due to growing resistance to various therapeutic chemical agents, the demand for high specificity biologics such as monoclonal antibodies is expected to increase during the forecast period.
• The injectable segment is anticipated to dominate the market by route of administration for administrating monoclonal antibodies.
• In terms of distribution channel, retail pharmacies are expected to gain more than 50% of market share during the forecast period.
• North America is the dominating region, while East Asia is expected to offer lucrative opportunities, owing to rapid increase in healthcare programs and industrialization.

Leading Manufacturers Following Acquisition Strategy to Increase Regional Presence

Leading manufacturers in the canine atopic dermatitis treatment market are focusing on regional acquisitions to enhance their product portfolios and expand their regional presence. For instance, in 2018, Zoetis completed the acquisition of Nexvet Biopharma. This collaboration strengthened the development platform of mAb therapies and added new alternatives to treat diseases in companion animals. In 2017, Elanco Animal Health (Eli Lily and Company) reported an acquisition of Boehringer Ingelheim Vetmedica, Inc., which includes an array of rabies vaccines, feline and canine products, and several pipeline assets.

Speak To Analyst For Queries about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-4412

Want more insights?

The canine atopic dermatitis treatment market, a new study by Future Market Insights, provides a market study on canine atopic dermatitis treatment from 2014–2018, and presents demand projections for 2019–2029, on the basis of drug class (corticosteroids, immunosuppressants, antibiotics, antihistamines, emollients, essential fatty acids, and antipruritics), mode of administration (topical, oral, and injectable), and distribution channel (veterinary hospitals, veterinary clinics, retail pharmacies, drug stores, and mail-order pharmacies), across seven prominent regions.

Reasons to Buy the report

• We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
• Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
• The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/4412

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com